Delivery Order SPE2DB25D3002-SPE2DB25FLPVM

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,632.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. It is a firm fixed-price contract, with no set-aside designation....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4,566,357,690 units of Candesartan Cilexetil 16 mg tablets. The contract, valued at $4,894.21, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract has no set-aside designation, indicating open...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,575.64 firm fixed-price delivery order contract is for the supply of Candesartan Cilexetil 16 mg Tablets, a cardiovascular medication, to support military healthcare programs. The contract has a period of performance through January 3, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.38 firm fixed-price delivery order is for the supply of 90-count bottles of 32mg Candesartan Cilexetil tablets. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $25,848.46, is for the supply of Candesartan Cilexetil 16 mg tablets. The award has an ultimate completion date of August 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $36,318.43 and an ultimate completion date of July 18, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these essential medication supplies to support military treatment facilities and...
This federal contract award, valued at $8,333.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a completion date of December 17, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $2,277.09 and a period of performance ending on August 2, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,235.63 firm fixed-price delivery order is for the supply of 4,566,770,606 units of Candesartan Cilexetil 8 mg tablets. The contract has a period of performance through December 20, 2024 and was awarded on December 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Candesartan Cilexetil 16 mg tablets. The $6,294.02 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on November 14, 2024, with a completion date of November 15, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLPVM
    Delivery Order

This federal contract award, valued at $7,570.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets in 90 count packages. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a completion date of January 14, 2025.

This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 4/14/25, 10:38 AM